Clinical Trials
32 trialsNivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
National Cancer Institute (NCI)
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
National Cancer Institute (NCI)
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
Eastern Cooperative Oncology Group
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
AIDS Malignancy Consortium
SAPPHIRE
Institut du Cancer de Montpellier - Val d'Aurelle
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
Duke University
ANA
Instituto do Cancer do Estado de São Paulo
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
University of California, San Francisco
INSPIRE
AHS Cancer Control Alberta
SANCA
Karolinska Institutet
Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
AIDS Malignancy Consortium
IMPAC
Tata Memorial Centre
VolATIL
Centre Hospitalier Universitaire de Besancon
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
University of Sao Paulo
PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients
Sun Yat-sen University
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
MIFADORESOL
Institut de cancérologie Strasbourg Europe
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
Eastern Cooperative Oncology Group
InterAACT
Eastern Cooperative Oncology Group
Epitopes-HPV02
Centre Hospitalier Universitaire de Besancon
Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
Sixth Affiliated Hospital, Sun Yat-sen University
LAND
Centre Hospitalier Universitaire de Besancon
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
UNICANCER
Epitopes-HPV01
Centre Hospitalier Universitaire de Besancon
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
Radiation Therapy Oncology Group
CCRPWAR
Sixth Affiliated Hospital, Sun Yat-sen University
BOOST-CA
Institut Paoli-Calmettes
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Radiation Therapy Oncology Group
A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy
AHS Cancer Control Alberta
A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.
Instituto do Cancer do Estado de São Paulo
Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
National Cancer Institute (NCI)